Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Næstved

32 clinical trials in Næstved, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Næstved at a glance
32
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

32 trials in Næstved

Open in trial search

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Stomatitis+1

Recruiting

A study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lidocaine Hydrochloride

Breast cancer+2

Recruiting

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Relay Therapeutics Inc.

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Region Oestergoetland

Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study of drug combination in patients with advanced cancer based on genomic profiling - ProTarget Danish nationwide trial

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cobimetinib
  • Sponsor:Rigshospitalet

Hip arthroplasty+1

Not yet recruiting

Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram
  • Sponsor:Sygehus Lillebaelt Vejle Sygehus

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Næstved

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on breast cancer treatments, including trials examining new combination therapies and targeted treatments for hormone receptor-positive and triple-negative variants.

  • Advanced/Metastatic Breast Cancer
  • Prostate Cancer Studies
  • Head and Neck Cancers

Multiple investigations into novel therapeutic approaches for various stages of prostate cancer, including hormone-sensitive and castration-resistant forms.

02 Respiratory Medicine

Clinical trials evaluating innovative treatments for severe asthma and chronic obstructive pulmonary disease, focusing on improving lung function and quality of life.

  • COPD Management
  • Eosinophilic Asthma
  • Bronchodilator Therapies

Studies examining the effectiveness of combination therapies and targeted biological treatments.

03 Cardiovascular Research

Investigations into post-myocardial infarction care and emergency cardiac treatments, with emphasis on improving patient outcomes.

  • Cardiac Arrest Management
  • Beta Blocker Studies
  • Emergency Cardiac Care

Research focusing on optimizing treatment strategies and emergency response protocols.

04 Orthopedic Studies

Research examining post-surgical care following hip and knee arthroplasties, including pain management and medication protocols.

  • Joint Replacement Outcomes
  • Post-Operative Pain Management
  • Surgical Recovery

Studies evaluating the safety and efficacy of various pain management approaches after major orthopedic procedures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.